Atyr Pharma Inc (NASDAQ:ATYR) concluded the trading at $4.43 on current market day with a rise of 4.24% from its closing price on previous day.
Considering stock’s 52-week price range provides that ATYR hit a high price of $4.28 and saw its price falling to a low level of $1.42 during that period. Over a period of past 1-month, stock came adding 22.04% in its value.
With its current market valuation of $371.87 million, Atyr Pharma Inc is set to declare its quarterly results in March. Analysts are in estimates of -0.23 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.91 for current year with estimates of that growing to -0.85 in next year.
In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 165.73k in current fiscal year, which will be -53.05% less from revenue generated by the company last year.
In contrast, when we review ATYR stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 100% Buy for it.
Digging deeper we become aware of the PEG ratio of the ATYR stock which is currently positioned at 0. It further provides that stock’s current price level is 18.23% away from its 20-day simple moving average and is 23.66% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 66.77 while volatility remained at 9.11% over the past week which changes to 6.86% when measuring it over the past month. Beta is valued at 1.00, while measure of average true range or ATR is currently at 0.28.
The percentage of outstanding shares held by the insiders is 3.22% while it is 65.86% for the institutional holders. Addition of 22.38% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
